SCHEMBL23288494

SCHEMBL23288494

CCCCCCCC/C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC/C=C/CCCCCCCC

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 2/20 0.78
MGLL Q99685 1/20 0.69
MAPT P10636 3/20 0.67
ALDH1A1 P00352 1/20 0.67
THRB P10828 1/20 0.67
CNR1 P21554 1/20 0.67
EPHX2 P34913 1/20 0.64
PRKCE Q02156 1/20 0.61
PRKCQ Q04759 1/20 0.61
PRKCD Q05655 1/20 0.61
PRKCA P17252 1/20 0.61
TERT O14746 3/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C19 P33261 2/20 0.61
BLM P54132 2/20 0.61
HSD17B10 Q99714 2/20 0.61
FABP4 P15090 2/20 0.61
FAAH O00519 2/20 0.61
PTPN1 P18031 2/20 0.61
PPARG P37231 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12961132 1.00 DGKA (0.78) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL29454683 1.00 DGKA (0.78) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL3776623 1.00 DGKA (0.78) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL285023 1.00 DGKA (0.78) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL3814806 1.00 DGKA (0.78) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL31171903 0.98 DGKA (0.75) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL7639501 0.95 MGLL (0.77) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL25298872 0.95 DGKA (0.69) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL25298871 0.95 DGKA (0.69) DGKAMGLLMAPTALDH1A1THRB
SCHEMBL25245199 0.95 DGKA (0.69) DGKAMGLLMAPTALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731175-A1 BETAINE MODIFIED POLY (AMINO ACID) S OR PROTEIN HYDROLYSATE BASF SE (DE) 2026-04-29 EP disclosed
US-12594232-B2 Personal care compositions and methods for using such compositions SPECIALTY OPERATIONS FRANCE (FR) 2026-04-07 US disclosed
US-20250388835-A1 CONCENTRATED CONTROLLED FOAM DETERGENT ECOLAB USA INC (US) 2025-12-25 US disclosed
US-20250375370-A1 PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS AND ITS IMPROVEMENT OF DISPERSIBILITY, STABILITY AND DEPOSITION EFFECTS BASF SE (DE) 2025-12-11 US disclosed
EP-3091968-B1 PROCESS FOR FORMING A MULTILAYERED SHAPED FILM KENVUE BRANDS LLC (US) 2025-10-29 EP disclosed
EP-4631494-A2 COMPOSITIONS SUITABLE FOR USE IN SKIN CARE Kenvue Brands LLC (US) 2025-10-15 EP disclosed
EP-4173612-B1 COMPOSITIONS SUITABLE FOR USE IN SKIN CARE KENVUE BRANDS LLC (US) 2025-08-27 EP disclosed
US-20250241842-A1 THERMO-SENSITIVE COMPOSITION AND METHOD FOR PREPARATION THEREOF BASF SE (DE) 2025-07-31 US disclosed
EP-4572734-A1 IMPROVED CLEANSING COMPOSITION Kenvue Brands LLC (US) 2025-06-25 EP disclosed
WO-2025119276-A1 THERMO-SENSITIVE PARTIALLY DEGALACTOSYLATED XYLOGLUCAN AND ITS USE FOR COSMETICS APPLICATIONS BASF SE (DE) 2025-06-12 WO disclosed
WO-2022137030-A1 COMPOSITIONS COMPRISING COCAMIDOPROPYL BETAINE AND AT LEAST ONE FATTY ACID JOHNSON & JOHNSON CONSUMER INC. (US) 2022-06-30 WO disclosed
US-20220192966-A1 A PERSONAL WASHING COMPOSITION AND METHOD OF ACHIEVING IMPROVED CONDITIONING BENEFITS BASF SE (DE) 2022-06-23 US disclosed
EP-4014957-A1 COMPOSITIONS COMPRISING COCAMIDOPROPYL BETAINE AND AT LEAST ONE FATTY ACID Johnson & Johnson Consumer Inc. (US) 2022-06-22 EP disclosed
WO-2022107856-A1 POROUS MEMBRANE 旭化成株式会社 2022-05-27 WO disclosed
CN-108697608-B Personal care compositions and methods of using such compositions 罗地亚经营管理公司 2022-04-12 CN disclosed
WO-2022072273-A1 SHAVING COMPOSITION FALLIEN COSMECEUTICALS, LTD. (US) 2022-04-07 WO disclosed
EP-3965898-A1 A PERSONAL WASHING COMPOSITION AND METHOD OF ACHIEVING IMPROVED CONDITIONING BENEFITS BASF SE (DE) 2022-03-16 EP disclosed
EP-3536313-B1 PROCESS FOR FORMING A SHAPED FILM PRODUCT JOHNSON & JOHNSON CONSUMER INC (US) 2022-02-16 EP disclosed
US-11247226-B2 Process for forming a multilayered shaped film product JOHNSON & JOHNSON CONSUMER INC. (US) 2022-02-15 US disclosed
WO-2021078249-A1 ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF 中国石油化工股份有限公司 2021-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388835-A1 CONCENTRATED CONTROLLED FOAM DETERGENT DSG1, DEGS1, SMURF1 DGKA 84/4885MGLL 509/4885MAPT 4153/4885
US-20250241842-A1 THERMO-SENSITIVE COMPOSITION AND METHOD FOR PREPARATION THEREOF LRBA, CUTA, PPIB DGKA 1376/4885MGLL 72/4885MAPT 630/4885
US-12594232-B2 Personal care compositions and methods for using such compositions FFAR2, FFAR3, CUTA DGKA 2897/4885MGLL 132/4885MAPT 2021/4885
US-20250375370-A1 PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS AND ITS IMPROVEMENT OF DISPERSIBILITY, STABILITY AND DEPOSITION EFFECTS KRT18, CUTA, PLOD3 DGKA 263/4885MGLL 67/4885MAPT 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.